Scientists test genetic vaccine to reboot immune system against stubborn hepatitis b
NCT ID NCT00988767
Summary
This early-stage study tested whether a new type of vaccine made from DNA could safely help the body's immune system fight chronic hepatitis B. It involved 10 patients whose infections had not responded to standard medications. The main goal was to check if the vaccine was safe and if it could restore the immune response needed to control the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service d'Hepatologie, Hopital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.